Tamer Elbayoumi

1.7k total citations
36 papers, 1.3k citations indexed

About

Tamer Elbayoumi is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Tamer Elbayoumi has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Tamer Elbayoumi's work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Tamer Elbayoumi is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Tamer Elbayoumi collaborates with scholars based in United States, Egypt and Switzerland. Tamer Elbayoumi's co-authors include Vladimir P. Torchilin, Vladimir P. Torchilin, Anatoly N. Lukyanov, Mu Li, Jimmy Tam Huy Pham, Volkmar Weissig, Mingyi Yao, V.H. Giang Phan, Jane J. Kim and Megha Joshi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Tamer Elbayoumi

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamer Elbayoumi United States 18 699 666 386 199 138 36 1.3k
Elaine Amaral Leite Brazil 24 722 1.0× 566 0.8× 427 1.1× 161 0.8× 113 0.8× 60 1.3k
Arehalli S. Manjappa India 18 498 0.7× 445 0.7× 258 0.7× 241 1.2× 111 0.8× 58 1.2k
Sohee Son South Korea 18 369 0.5× 743 1.1× 301 0.8× 189 0.9× 72 0.5× 44 1.4k
Renata Salgado Fernandes Brazil 22 504 0.7× 439 0.7× 371 1.0× 95 0.5× 80 0.6× 39 1.0k
Brij K. Gupta United States 9 588 0.8× 564 0.8× 316 0.8× 181 0.9× 41 0.3× 15 1.4k
Gigi Ngar Chee Chiu Singapore 20 650 0.9× 616 0.9× 439 1.1× 119 0.6× 50 0.4× 32 1.4k
Yanqiang Zhong China 24 638 0.9× 638 1.0× 469 1.2× 361 1.8× 66 0.5× 45 1.6k
Hui Ding United States 25 656 0.9× 690 1.0× 479 1.2× 58 0.3× 163 1.2× 55 1.6k
Juliette Vergnaud France 22 364 0.5× 676 1.0× 312 0.8× 116 0.6× 56 0.4× 46 1.3k
Manuela Banciu Romania 22 422 0.6× 535 0.8× 338 0.9× 134 0.7× 63 0.5× 52 1.5k

Countries citing papers authored by Tamer Elbayoumi

Since Specialization
Citations

This map shows the geographic impact of Tamer Elbayoumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer Elbayoumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer Elbayoumi more than expected).

Fields of papers citing papers by Tamer Elbayoumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamer Elbayoumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer Elbayoumi. The network helps show where Tamer Elbayoumi may publish in the future.

Co-authorship network of co-authors of Tamer Elbayoumi

This figure shows the co-authorship network connecting the top 25 collaborators of Tamer Elbayoumi. A scholar is included among the top collaborators of Tamer Elbayoumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamer Elbayoumi. Tamer Elbayoumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zahoor, Insha, et al.. (2024). Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis. Heliyon. 10(15). e35753–e35753. 3 indexed citations
3.
Borchard, Gerrit, Matthias G. Wacker, Giorgia Pastorin, et al.. (2022). Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine. SHILAP Revista de lepidopterología. 10(1). 17–17. 8 indexed citations
4.
5.
Weissig, Volkmar & Tamer Elbayoumi. (2020). Pharmaceutical nanotechnology : basic protocols. Humana Press eBooks. 12 indexed citations
6.
Yao, Mingyi & Tamer Elbayoumi. (2019). Anionic and Cationic Vitamin E-TPGS Mixed Polymeric Phospholipid Micellar Vehicles. Methods in molecular biology. 2000. 31–41. 5 indexed citations
7.
8.
Vo, Kathy T., et al.. (2016). Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas. International Journal of Molecular Sciences. 17(11). 1792–1792. 20 indexed citations
9.
Nagaraj, Vinay J., et al.. (2015). Development and In Vitro Evaluation of Vitamin E-Enriched Nanoemulsion Vehicles Loaded with Genistein for Chemoprevention Against UVB-Induced Skin Damage. Journal of Pharmaceutical Sciences. 104(10). 3510–3523. 43 indexed citations
10.
Elbayoumi, Tamer, et al.. (2015). Layered nanoemulsions as mucoadhesive buccal systems for controlled delivery of oral cancer therapeutics. International Journal of Nanomedicine. 10. 1569–1569. 37 indexed citations
11.
Pham, Jimmy Tam Huy, Oliver Grundmann, & Tamer Elbayoumi. (2015). Mitochondriotropic Nanoemulsified Genistein-Loaded Vehicles for Cancer Therapy. Methods in molecular biology. 1265. 85–101. 15 indexed citations
12.
Pham, Jimmy Tam Huy, et al.. (2014). Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas. Drug Delivery. 23(5). 1–11. 29 indexed citations
13.
Phan, V.H. Giang, et al.. (2013). Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas. Journal of drug targeting. 21(10). 1001–1011. 46 indexed citations
14.
Elbayoumi, Tamer, et al.. (2012). Development and Evaluation of Tocopherol-Rich Argan Oil-Based Nanoemulsions as Vehicles Possessing Anticancer Activity. Journal of Biomedical Nanotechnology. 8(6). 944–956. 23 indexed citations
15.
Elbayoumi, Tamer & Vladimir P. Torchilin. (2009). Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody. Clinical Cancer Research. 15(6). 1973–1980. 125 indexed citations
16.
Elbayoumi, Tamer & Vladimir P. Torchilin. (2008). Tumor-specific antibody-mediated targeted delivery of Doxil® reduces the manifestation of auricular erythema side effect in mice. International Journal of Pharmaceutics. 357(1-2). 272–279. 51 indexed citations
17.
Elbayoumi, Tamer, et al.. (2007). Antinucleosome Antibody-Modified Liposomes and Lipid-Core Micelles for Tumor-Targeted Delivery of Therapeutic and Diagnostic Agents. Journal of Liposome Research. 17(1). 1–14. 60 indexed citations
18.
Elbayoumi, Tamer & Vladimir P. Torchilin. (2007). Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. European Journal of Pharmaceutical Sciences. 32(3). 159–168. 84 indexed citations
19.
Elbayoumi, Tamer & Vladimir P. Torchilin. (2006). Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. European Journal of Nuclear Medicine and Molecular Imaging. 33(10). 1196–1205. 71 indexed citations
20.
Lukyanov, Anatoly N., et al.. (2004). Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. Journal of Controlled Release. 100(1). 135–144. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine Amaral Leite Breakdown of academic impact, for papers by Arehalli S. Manjappa Breakdown of academic impact, for papers by Sohee Son Breakdown of academic impact, for papers by Renata Salgado Fernandes Breakdown of academic impact, for papers by Brij K. Gupta Breakdown of academic impact, for papers by Gigi Ngar Chee Chiu Breakdown of academic impact, for papers by Yanqiang Zhong Breakdown of academic impact, for papers by Hui Ding Breakdown of academic impact, for papers by Juliette Vergnaud Breakdown of academic impact, for papers by Manuela Banciu
Rankless by CCL
2026